homocysteic acid has been researched along with Blood Pressure, Low in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Göktalay, G; Levendusky, MC; Millington, WR | 1 |
| Bandler, R; Christie, MJ; Crowfoot, LJ; Floyd, NS; Henderson, LA; Keay, KA | 1 |
| Germanson, TP; Guyenet, PG; Wang, H | 1 |
3 other study(ies) available for homocysteic acid and Blood Pressure, Low
| Article | Year |
|---|---|
Muscimol injection into the lateral hypothalamus inhibits the hypotension and bradycardia caused by somato-visceral nociception.
Topics: Animals; Bradycardia; Cardiovascular Physiological Phenomena; GABA Agonists; Homocysteine; Hypotension; Hypothalamic Area, Lateral; Male; Microinjections; Muscimol; Pain; Rats; Rats, Sprague-Dawley | 2004 |
Cardiovascular effects of microinjections of opioid agonists into the 'Depressor Region' of the ventrolateral periaqueductal gray region.
Topics: Analgesics; Animals; Benzeneacetamides; Blood Pressure; Bradycardia; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Excitatory Amino Acids; Heart Rate; Homocysteine; Hypertension; Hypotension; Male; Microinjections; Neural Inhibition; Pain; Periaqueductal Gray; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1997 |
Depressor and tachypneic responses to chemical stimulation of the ventral respiratory group are reduced by ablation of neurokinin-1 receptor-expressing neurons.
Topics: Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Cell Count; Dose-Response Relationship, Drug; Homocysteine; Hypertension; Hypotension; Immunotoxins; Male; Medulla Oblongata; Microinjections; N-Glycosyl Hydrolases; Neurons; Phrenic Nerve; Plant Proteins; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Recombinant Fusion Proteins; Respiration; Respiratory Physiological Phenomena; Ribosome Inactivating Proteins, Type 1; Saporins; Substance P | 2002 |